An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2

Gene Therapy
M WrightD T Curiel

Abstract

We previously demonstrated that delivery of a gene encoding an anti-erbB-2 intracellular single-chain antibody (sFv) resulted in down-regulation of cell surface erbB-2 levels and induction of apoptosis in erbB-2 overexpressing ovarian cancer cells. Based upon these findings, we hypothesized that human breast carcinomas overexpressing erbB-2 would be similarly affected by this genetic intervention. We evaluated the phenotypic effects resulting from intracellular expression of the anti-erbB-2 sFv on the human breast cancer cell lines MDA-MB-361, SK-BR-3, BT-474, MCF-7 and MDA-MB-231. Recombinant adenoviruses encoding either a reporter gene (AdCMVLacZ) or the endoplasmic reticulum (ER) directed anti-erbB-2 sFv (Ad21) were delivered to various breast cancer cell lines. Cell viability was determined by a proliferation assay and fluorescent microscopy allowed visualization of apoptotic cells. An erbB-2 ELISA quantified the endogenous erbB-2 levels of each cell line. The anti-erbB-2 sFv-encoding-adenovirus, Ad21, but not the beta-galactosidase encoding adenovirus, AdCMVLacZ, was cytotoxic to > 95% of the tumor cells in the MDA-MB-361 and SK-BR-3 lines, and > 60% of the tumor cells in the BT-474 line. In marked contrast, the MCF-7 and ...Continue Reading

Citations

Jan 7, 2000·Journal of Cellular Physiology·S MénardS M Pupa
Jul 6, 2000·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·D Yu, M C Hung
Jul 20, 1999·Journal of Immunological Methods·R E Kontermann, R Müller
Feb 18, 1999·Current Opinion in Chemical Biology·D A Jones, F A Fitzpatrick
Jul 16, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jin-Shing ChenMien-Chie Hung
Jun 1, 1997·Breast Cancer Research and Treatment·J M RuppertT V Strong
Jan 18, 2006·Cancer Gene Therapy·M A Stoff-KhaliliD T Curiel
Oct 30, 1998·Human Gene Therapy·M PelegrinM Piechaczyk
Feb 15, 2013·Journal of Virology·Wondimagegnehu M TeferiDavid H Evans
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·E Tse, T H Rabbitts
Aug 8, 2015·MAbs·Andrea L J MarschallThomas Böldicke
Jun 16, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shih-Jiuan ChiuRobert J Lee
Apr 15, 1999·Seminars in Cancer Biology·J S Ross, J A Fletcher
May 31, 2007·American Journal of Physiology. Endocrinology and Metabolism·Subbiah PugazhenthiJawed Alam
Mar 16, 2001·Breast Cancer Research : BCR·D T Curiel
Mar 16, 2001·Breast Cancer Research : BCR·J Gómez-NavarroJ Xiang
Oct 16, 1999·International Journal of Cancer. Journal International Du Cancer·N UedoA Nakaizumi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.